Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)

Clinical trial NCT00093964 · COMPLETED

Trial details

NCT number: NCT00093964
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2004-10-13
Primary completion: 2005-10-28
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.